Helicobacter pylori strain ZH24 30

Helicobacter pylori strain ZH24 30 is a Gram-negative, microaerophilic bacterium characterized by its spirilla shape and the presence of flagella, which aids in its motility. This strain is predominantly associated with various hosts, including Homo sapiens (humans), Gallus gallus (chickens), and several other mammals and birds. It exhibits a free-living biotic relationship and thrives optimally at 37°C, aligning with its mesophilic temperature range. The strain possesses a single replicon and is structured with two membranes. Its habitat is primarily host-associated, indicating a close relationship with its hosts, where it can contribute to significant health impacts. Notably, H. pylori is linked to a range of gastrointestinal diseases, including chronic gastric inflammation, gastric ulcers, and various forms of gastric cancer, such as adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. The bacterium is implicated in conditions like gastroesophageal reflux disease (GERD) and atrophic gastritis, showcasing its role in both symptomatic and asymptomatic inflammatory responses in the gastric mucosa. The pathogenicity of H. pylori strain ZH24 30 in humans highlights its importance in understanding gastrointestinal health and disease. The bacterium's association with serious health effects emphasizes the need for continued research into its mechanisms and the potential for therapeutic interventions. Its presence across multiple host species also suggests a broader ecological role in the microbiome dynamics of humans and other animals.